Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor

J Med Chem. 2004 Nov 4;47(23):5612-5. doi: 10.1021/jm0495834.

Abstract

We present and examine the efficacy of a novel benzoxepin-based scaffold for modulation of the human estrogen receptor. Receptor tolerance of this new molecular scaffold is examined through presentation of experimentally determined antiproliferative effects on human MCF-7 breast tumor cells and measured binding affinities. The effect of functional group substitution on the benzoxepin scaffold is explored through a brief computational structure-activity relationship investigation with molecular simulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Benzoxepins / chemical synthesis*
  • Benzoxepins / chemistry
  • Benzoxepins / pharmacology
  • Cell Line, Tumor
  • Estrogen Receptor Modulators / chemical synthesis*
  • Estrogen Receptor Modulators / chemistry
  • Estrogen Receptor Modulators / pharmacology
  • Humans
  • Inhibitory Concentration 50
  • Models, Molecular
  • Receptors, Estrogen / chemistry
  • Receptors, Estrogen / drug effects*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Benzoxepins
  • Estrogen Receptor Modulators
  • Receptors, Estrogen